๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma

โœ Scribed by Lahtinen, Reino; Laakso, Markku; Palva, Ilmari; Elomaa, Inkeri; Virkkunen, Pekka

Book ID
122687834
Publisher
The Lancet
Year
1992
Tongue
English
Weight
550 KB
Volume
340
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Ocrelizumab in relapsing-remitting multi
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
โœ Ludwig Kappos; David Li; Peter A Calabresi; Paul O'Connor; Amit Bar-Or; Frederik ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› The Lancet ๐ŸŒ English โš– 337 KB

## Background: B lymphocytes are implicated in the pathogenesis of multiple sclerosis. we aimed to assess efficacy and safety of two dose regimens of the humanised anti-cd20 monoclonal antibody ocrelizumab in patients with relapsing-remitting multiple sclerosis. ## Methods: We did a multicentre,